Thymosin Alpha-1 is an immune-modulating compound that is formally approved as a pharmaceutical product in more than 30 countries including Italy, China, and several Southeast Asian nations for the treatment of hepatitis B, hepatitis C, and as an immune adjuvant in oncology
These medications are FDA-approved for chronic weight management in adults with a BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity, regardless of bariatric surgery history
Starting Dose: 0.25 mg once daily Optimal Dose: 0.25 to 0.5 mg daily, with option to split into two doses Administration: Subcutaneous injection, abdomen preferred for systemic effects Timing: Morning injection, at least 2 hours away from Retatrutide Duration: 4 to 8 weeks cycles with 2 to 4 weeks off between What the Research Community Reports User experiences with BPC-157 alongside Retatrutide consistently highlight reduced GI symptoms
Feel Better, Function Better, with B12 Keep up with the life you love
I hope you feel some improvement soon and sorry to hear your having such a rough time
